
TIANYU BIO-TECHNOLOGY CO.,LTD. — Investor Relations & Filings
TIANYU BIO-TECHNOLOGY CO.,LTD. specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and advanced pharmaceutical intermediates. The company focuses on therapeutic areas such as cardiovascular health, diabetes management, and anti-viral treatments. Its core product portfolio includes various sartan-based intermediates and other complex organic synthesis products. TIANYU BIO-TECHNOLOGY emphasizes rigorous quality management systems and adheres to international regulatory standards to ensure product safety and efficacy. By leveraging advanced chemical synthesis technologies and a robust R&D infrastructure, the company provides customized manufacturing solutions and high-quality chemical components to global pharmaceutical partners. Its operations are characterized by a commitment to technical innovation and process optimization in the synthesis of complex molecules.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 监事会关于2022年股票期权激励计划首次授予股票期权激励对象名单的核查意见(授权日) | 2022-05-11 | Chinese | |
| 2022年股票期权激励计划首次授予股票期权激励对象名单(授权日) | 2022-05-11 | Chinese | |
| 天域生态第三届董事会第四十四次会议决议公告 | 2022-05-11 | Chinese | |
| 天域生态环境股份有限公司关于召开2021年度业绩说明会暨问题征集的公告 | 2022-04-29 | Chinese | |
| 天域生态2022年第一季度主要经营数据公告 | 2022-04-29 | Chinese | |
| 2021年年度股东大会会议资料 | 2022-04-29 | Chinese |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
15 filings
| |||||
| 38180333 | 监事会关于2022年股票期权激励计划首次授予股票期权激励对象名单的核查意见(授权日) | 2022-05-11 | Chinese | ||
| 38180317 | 2022年股票期权激励计划首次授予股票期权激励对象名单(授权日) | 2022-05-11 | Chinese | ||
| 38180300 | 天域生态第三届董事会第四十四次会议决议公告 | 2022-05-11 | Chinese | ||
| 38180289 | 天域生态环境股份有限公司关于召开2021年度业绩说明会暨问题征集的公告 | 2022-04-29 | Chinese | ||
| 38180278 | 天域生态2022年第一季度主要经营数据公告 | 2022-04-29 | Chinese | ||
| 38180258 | 2021年年度股东大会会议资料 | 2022-04-29 | Chinese | ||
| 38180246 | 天域生态2022年第一季度报告 | 2022-04-29 | Chinese | ||
| 38180231 | 关于公司2021年度利润分配预案的公告 | 2022-04-25 | Chinese | ||
| 38180218 | 关于天域生态环境股份有限公司2021年度募集资金存放与实际使用情况的专项鉴证报告 | 2022-04-25 | Chinese | ||
| 38180158 | 关于公司2022年度对外担保预计的公告 | 2022-04-25 | Chinese | ||
| 38180145 | 第三届监事会第二十三次会议决议公告 | 2022-04-25 | Chinese | ||
| 38180129 | 关于召开2021年年度股东大会的通知 | 2022-04-25 | Chinese | ||
| 38180104 | 中德证券有限责任公司关于天域生态环境股份有限公司向控股股东借款暨关联交易的核查意见 | 2022-04-25 | Chinese | ||
| 38180084 | 关于2022年度续聘会计师事务所的公告 | 2022-04-25 | Chinese | ||
| 38180074 | 中德证券有限责任公司关于天域生态环境股份有限公司向控股股东借款暨关联交易的核查意见 | 2022-04-25 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
TIANYU BIO-TECHNOLOGY CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/57798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=57798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=57798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=57798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 57798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for TIANYU BIO-TECHNOLOGY CO.,LTD. (id: 57798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.